Barcelona, Spain · Founded 2012 · Privately Held (backing)
Operator of a biotechnology company intended to develop genetic medicines through protein-splicing gene therapy. SpliceBio is based in Barcelona, Spain and was founded in 2012. Its last reported valuation was $84.5 million in Feb 2022. It has raised $198 million.
Last reported valuation
$84.5M
Oct 2026
Priced at
—
Total raised
$198.0M
Last round
—
Cap table — not yet on record
SpliceBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SpliceBio with a free account
·The complete investor list: 11 names
·Watch SpliceBio: the Monday email on marks, rounds and moves
